COPENHAGEN. Denmark has decided to exclude the Johnson & Johnson vaccine from the Covid vaccination program. Denmark justified its decision with concerns about serious side effects related to blood clot formation. “The Danish Health Authority has concluded that the benefits of using Johnson & Johnson’s Covid-19 vaccine do not outweigh the risk of causing the possible adverse effect in those receiving the vaccine,” the Danish health authority said in a statement. press release. WHO and EMA have both authorized the vaccine.
In the note, the Danish health authority specified that the European Medicines Agency (EMA) concluded that “there is a possible link between rare but serious cases of blood clots and the Johnson & Johnson Covid-19 vaccine“. “Since the Covid-19 epidemic in Denmark is currently under control and the implementation of vaccination is progressing satisfactorily with other available vaccines, the Danish Health Authority has decided to continue the national vaccination campaign”, without the serum by Johnson & Johnson. The decision was taken on Monday in a meeting in parliament between the Minister of Health, Magnus Heunicke, and deputies from the various parties. Vaccines manufactured by Pfizer-BioNTech and Moderna account for the majority of the doses administered in the Scandinavian country of nearly 6 million people. According to official data, more than 1.2 million residents have received the first or both doses.